NeuroOne Medical Technologies, headquartered in Eden Prairie, Minnesota, develops thin film electrode technology for neurodiagnostic and treatment solutions, focusing on conditions like epilepsy and chronic pain. The company went public on November 9, 2012, and employs 16 people.
David A Rosa bought 100,000 shares of NMTC on 4 April at $0.50 per share, worth a total of $50K. They now own 1,161,289 NMTC shares, or a 9% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
